US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist

7.760
+0.350+4.72%

Close Mar 28 16:00 ET

7.760
0.0000.00%

Post 16:05 ET

259.37MMarket Cap-4.19P/E (TTM)

MBX Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-71.00%-54.68M

-43.88%-16.04M

-89.80%-14.66M

-38.30%-31.98M

-11.15M

-7.73M

-23.12M

Net income from continuing operations

-90.16%-61.92M

-76.25%-15.59M

-78.51%-18.14M

-24.60%-32.56M

---8.84M

---10.16M

---26.14M

Operating gains losses

----

-92.90%69K

----

--972K

Depreciation and amortization

55.41%244K

41.46%58K

87.50%75K

180.36%157K

--41K

--40K

--56K

Other non cash items

11.58%106K

8.00%27K

12.50%27K

-77.16%95K

--25K

--24K

--416K

Change In working capital

725.44%4.6M

78.05%-627K

54.63%2.77M

-156.98%-735K

---2.86M

--1.79M

--1.29M

-Change in prepaid assets

-124.26%-2.35M

22.16%-1.03M

-562.60%-569K

-32.36%-1.05M

---1.32M

--123K

---791K

-Change in payables and accrued expense

1,453.17%7.1M

129.64%442K

98.24%3.38M

-78.47%457K

---1.49M

--1.7M

--2.12M

-Change in other current assets

--0

----

80.95%-8K

----

---42K

-Change in other current liabilities

-11.68%-153K

-14.29%-40K

-8.57%-38K

---137K

---35K

--0

Cash from discontinued investing activities

Operating cash flow

-71.00%-54.68M

-43.88%-16.04M

-89.80%-14.66M

-38.30%-31.98M

---11.15M

---7.73M

---23.12M

Investing cash flow

Cash flow from continuing investing activities

-419.27%-160.6M

-132.59%-67.35M

-441.73%-100.79M

-171.03%-30.93M

-28.96M

-18.61M

-11.41M

Net PPE purchase and sale

-577.52%-874K

-67.27%-92K

-159.09%-57K

70.75%-129K

---55K

---22K

---441K

Net investment purchase and sale

-418.61%-159.72M

-132.71%-67.25M

-442.06%-100.73M

-180.75%-30.8M

---28.9M

---18.58M

---10.97M

Cash from discontinued investing activities

Investing cash flow

-419.27%-160.6M

-132.59%-67.35M

-441.73%-100.79M

-171.03%-30.93M

---28.96M

---18.61M

---11.41M

Financing cash flow

Cash flow from continuing financing activities

238.21%234.1M

-794.74%-132K

244.27%235.81M

50.27%69.22M

19K

68.5M

46.06M

Net issuance payments of debt

----

--10M

Net common stock issuance

--174.54M

--0

----

--0

----

Net preferred stock issuance

-7.31%63.5M

--0

----

87.74%68.51M

--0

----

--36.49M

Proceeds from stock option exercised by employees

-45.47%403K

926.32%195K

-282.35%-31K

2,363.33%739K

--19K

--17K

--30K

Net other financing activities

-14,370.00%-4.34M

---327K

---2.2M

93.45%-30K

--0

----

---458K

Cash from discontinued financing activities

Financing cash flow

238.21%234.1M

-794.74%-132K

244.27%235.81M

50.27%69.22M

--19K

--68.5M

--46.06M

Net cash flow

Beginning cash position

26.08%30.52M

88.18%132.87M

-56.04%12.5M

90.93%24.21M

--70.61M

--28.44M

--12.68M

Current changes in cash

198.24%18.83M

-108.36%-83.51M

185.45%120.36M

-45.25%6.31M

---40.08M

--42.17M

--11.53M

End cash Position

61.68%49.35M

88.18%132.87M

26.08%30.52M

--30.52M

--70.61M

--24.21M

Free cash flow

-73.03%-55.56M

-44.00%-16.13M

-90.00%-14.72M

-36.26%-32.11M

---11.2M

---7.75M

---23.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-71.00%-54.68M	-43.88%-16.04M	-89.80%-14.66M	-38.30%-31.98M	-11.15M	-7.73M	-23.12M
Net income from continuing operations	-90.16%-61.92M	-76.25%-15.59M	-78.51%-18.14M	-24.60%-32.56M	---8.84M	---10.16M	---26.14M
Operating gains losses	----	----	----	-92.90%69K	----	----	--972K
Depreciation and amortization	55.41%244K	41.46%58K	87.50%75K	180.36%157K	--41K	--40K	--56K
Other non cash items	11.58%106K	8.00%27K	12.50%27K	-77.16%95K	--25K	--24K	--416K
Change In working capital	725.44%4.6M	78.05%-627K	54.63%2.77M	-156.98%-735K	---2.86M	--1.79M	--1.29M
-Change in prepaid assets	-124.26%-2.35M	22.16%-1.03M	-562.60%-569K	-32.36%-1.05M	---1.32M	--123K	---791K
-Change in payables and accrued expense	1,453.17%7.1M	129.64%442K	98.24%3.38M	-78.47%457K	---1.49M	--1.7M	--2.12M
-Change in other current assets	--0	----	----	80.95%-8K	----	----	---42K
-Change in other current liabilities	-11.68%-153K	-14.29%-40K	-8.57%-38K	---137K	---35K	---35K	--0
Cash from discontinued investing activities
Operating cash flow	-71.00%-54.68M	-43.88%-16.04M	-89.80%-14.66M	-38.30%-31.98M	---11.15M	---7.73M	---23.12M
Investing cash flow
Cash flow from continuing investing activities	-419.27%-160.6M	-132.59%-67.35M	-441.73%-100.79M	-171.03%-30.93M	-28.96M	-18.61M	-11.41M
Net PPE purchase and sale	-577.52%-874K	-67.27%-92K	-159.09%-57K	70.75%-129K	---55K	---22K	---441K
Net investment purchase and sale	-418.61%-159.72M	-132.71%-67.25M	-442.06%-100.73M	-180.75%-30.8M	---28.9M	---18.58M	---10.97M
Cash from discontinued investing activities
Investing cash flow	-419.27%-160.6M	-132.59%-67.35M	-441.73%-100.79M	-171.03%-30.93M	---28.96M	---18.61M	---11.41M
Financing cash flow
Cash flow from continuing financing activities	238.21%234.1M	-794.74%-132K	244.27%235.81M	50.27%69.22M	19K	68.5M	46.06M
Net issuance payments of debt	----	----	----	----	----	----	--10M
Net common stock issuance	--174.54M	--0	----	--0	--0	----	----
Net preferred stock issuance	-7.31%63.5M	--0	----	87.74%68.51M	--0	----	--36.49M
Proceeds from stock option exercised by employees	-45.47%403K	926.32%195K	-282.35%-31K	2,363.33%739K	--19K	--17K	--30K
Net other financing activities	-14,370.00%-4.34M	---327K	---2.2M	93.45%-30K	--0	----	---458K
Cash from discontinued financing activities
Financing cash flow	238.21%234.1M	-794.74%-132K	244.27%235.81M	50.27%69.22M	--19K	--68.5M	--46.06M
Net cash flow
Beginning cash position	26.08%30.52M	88.18%132.87M	-56.04%12.5M	90.93%24.21M	--70.61M	--28.44M	--12.68M
Current changes in cash	198.24%18.83M	-108.36%-83.51M	185.45%120.36M	-45.25%6.31M	---40.08M	--42.17M	--11.53M
End cash Position	61.68%49.35M	61.68%49.35M	88.18%132.87M	26.08%30.52M	--30.52M	--70.61M	--24.21M
Free cash flow	-73.03%-55.56M	-44.00%-16.13M	-90.00%-14.72M	-36.26%-32.11M	---11.2M	---7.75M	---23.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--

Market Insights

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Collegium Pharmaceutical

AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS

AIPUY

0.00%

Unlock the Full List